Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.3120
-0.0100 (-3.11%)
Last updated: Aug 3, 2026, 3:02 PM CET

EPA:ALOPM Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.310.440.3213.370
Short-Term Investments
1.84.8410.01--
Cash & Short-Term Investments
2.115.2710.3413.370
Cash Growth
-59.89%-48.99%-22.72%1337343.90%-
Accounts Receivable
0.340.621.060.48-
Other Receivables
0.222.32.682.41-
Total Trade Receivables
0.562.923.742.89-
Other Current Assets
0.140.460.320.14-
Total Current Assets
13.288.6614.416.410
Net Property, Plant & Equipment
0.50.630.760.9-
Other Intangible Assets
1.051.081.150.79-
Long-Term Investments
0.040.080.06--
Other Long-Term Assets
0.120.260.260.27-
Total Assets
14.9910.7116.6318.370
Accounts Payable
1.452.242.892.98-
Accrued Expenses
1.30.851.190.98-
Unearned Revenue
0.030.130.03--
Total Current Liabilities
2.793.224.113.96-
Long-Term Debt
6.367.588.832.6-
Other Long-Term Liabilities
0.010.3400.02-
Total Long-Term Liabilities
6.377.928.832.62-
Total Liabilities
9.1511.1412.946.59-
Common Stock
1.856.225.75.680
Additional Paid-in Capital
0.095.594.374.39-
Retained Earnings
-0.06-15.53-8.32-0.23-
Total Common Shareholders' Equity
1.89-3.721.759.840
Minority Interest
7.836.581.943.88-
Shareholders' Equity
9.722.863.6913.720
Total Liabilities & Equity
14.9910.7116.6318.370
Total Debt
6.367.588.832.60
Net Cash (Debt)
-4.24-2.311.5110.770
Net Cash Growth
---85.98%1076987.80%-
Net Cash Per Share
-0.23-0.130.090.651.00
Book Value
1.89-3.721.759.840
Book Value Per Share
0.10-0.200.100.591.00
Tangible Book Value
0.84-4.80.69.050
Tangible Book Value Per Share
0.05-0.260.040.541.00